Interpharma Equity (Malaysia) Sdn. Bhd. is a Malaysia-based holding and investment company within the Zuellig Pharma Group, one of Asia's leading healthcare services providers. The company holds equity interests in pharmaceutical distribution, marketing, and healthcare services businesses operating in Malaysia. Its activities support the group's integrated healthcare platform, which spans pharmaceutical distribution, product access, clinical trial support, and patient-centric services. Interpharma Equity plays a strategic role in structuring investments, managing ownership interests, and supporting long-term growth initiatives in Malaysia's healthcare sector. Strategically, the company focuses on capital deployment, governance, and portfolio optimisation aligned with Zuellig Pharma's regional healthcare expansion strategy.
Headquarters
15, Level 2, Persiaran Pasak Bumi, Seksyen U8, Perindustrian Bukit Jelutong
Shah Alam; Selangor;
Postal Code: 40150
Contact Details: Purchase the Interpharma Equity (Malaysia) Sdn. Bhd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service